IBM - The AI Eye: Episode 324 - IBM Makes Watson Assistant for Citizens Available to Help with COVID-19 Information Docebo Integrates with LogMeIn's GoTo Solutions

Point Roberts, WA and Vancouver, BC - April 2, 2020 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today's podcast:

https://www.investorideas.com/Audio/Podcasts/2020/040220-AI-Eye.mp3

SHARE PODCAST:

Hear the AI Eye on Spotify

Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:IBM) (TSX:DCBO) (NasdaqGS:LOGM)

IBM (NYSE:IBM) has made the Watson Assistant for Citizens, which leverages Natural Language Processing and AI, available for free to understand and respond to common questions about COVID-19. Rob Thomas, general manager, IBM Data & AI, explained:

"While helping government agencies and healthcare institutions use AI to get critical information out to their citizens remains a high priority right now, the current environment has made it clear that every business in every industry should find ways to digitally engage with their clients and employees. With today's news, IBM is taking years of experience in helping thousands of global businesses and institutions use Natural Language Processing and other advanced AI technologies to better meet the demands of their constituents, and now applying it to the COVID-19 crisis. AI has the power to be your assistant during this uncertain time."

AI-powered learning platform Docebo Inc. (TSX:DCBO) has announced new integrations with GoTo by LogMeIn, Inc. (NasdaqSG:LOGM). This brings together the former's virtual instructor-led training with the latter's cloud-based communications and collaboration solution. Craig Gleason, Director of Partnership at Docebo, said:

"At Docebo, we haven't let working remotely stop us from connecting and learning, and we want to help others to do the same. With this integration, our customers will be able to provide scalable in-person Virtual Learning meeting capabilities to remote audiences around the world."

Global AIaaS Market to Reach $77.04 Billion by 2025

A report from Allied Market Research finds that the global Artificial Intelligence as a Service (AIaaS) market will reach $77.04 billion in 2025 with a compound annual growth rate (CAGR) of 56.7 percent in the forecast period 2018-2025. An excerpt from the report overview reads:

The growth in expenditure on adoption of artificial intelligence and technological advancement for workflow optimization increase[s] the demand for advanced analytical systems in the market. Moreover, [the] rise in adoption of cloud-based solutions and surge in requirement[s] for artificial intelligence and cognitive computing market are the major factors that boost the growth of the AIaaS market. However, [the] dearth of trained professionals is expected to hinder the growth. Furthermore, increased application areas and growth in demand for IoT are projected to provide lucrative opportunities for the artificial intelligence as a service market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800 665 0411